The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Castlight Health Inc

NYSE: CSLT
Last

(U.S.) $2.64

Today's change0.00 0.00%
Updated February 11 4:00 PM EST. Delayed by at least 15 minutes.
 

Castlight Health Inc

NYSE: CSLT
Last

(U.S.) $2.64

Today's change0.00 0.00%
Updated February 11 4:00 PM EST. Delayed by at least 15 minutes.

Castlight Health Inc closed at (U.S.)$2.64.

Over the last five days, shares have lost 22.58% and sit 3.94% above their 52-week low. This security has underperformed the S&P 500 by 57.73% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $2.64
  • High--
  • Low--
  • Bid / Ask(U.S.) $2.21 / (U.S.) $3.00
  • YTD % change-38.17%
  • Volume0
  • Average volume (10-day)384,749
  • Average volume (1-month)496,651
  • Average volume (3-month)648,607
  • 52-week range(U.S.) $2.54 to (U.S.) $10.36
  • Beta--
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.87
Updated February 11 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-117.61%

Castlight Health Inc has a net profit margin of -117.61%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Company News

    No News Results.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue20191614
Total other revenue--------
Total revenue20191614
Gross profit111098
Total cost of revenue9877
Total operating expense40403634
Selling / general / administrative23242221
Research & development8776
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-20-21-20-20
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-20-21-20-20
Income after tax-20-21-20-20
Income tax, total--------
Net income-20-21-20-20
Total adjustments to net income--------
Net income before extra. items-20-21-20-20
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-20-21-20-20
Inc. avail. to common incl. extra. items-20-21-20-20
Diluted net income-20-21-20-20
Dilution adjustment--------
Diluted weighted average shares94949290
Diluted EPS excluding extraordinary itemsvalue per share-0.21-0.23-0.21-0.22
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.21-0.23-0.21-0.22